Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00178295 · ClinicalTrials.gov registry record
Radiation-Induced Cytokine Cascades and Their Correlation With Central Nervous System Injury
A clinical trial of Brain Neoplasm, sponsored by University of Rochester.
- Completed
- Registry status
- 44
- Enrollment target
- 1
- Study location
NCT00178295: Completed study of Brain Neoplasm, sponsored by University of Rochester.
NCT00178295 is a study of Brain Neoplasm that has completed, run by University of Rochester. The registered enrollment target is 44 participants, below the 49-participant average among 9 other Brain Neoplasm trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00178295, a study of Brain Neoplasm, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
Treatment for brain cancer may include radiation therapy. Radiation therapy is the treatment of tumors with X-rays. This study is related to understanding the side effects of radiation treatment for brain tumors. This study is being conducted by the University of Rochester Cancer Center to compare the extent of side effects of brain cancer treatment with changes in levels of blood proteins called cytokines.
Conditions Studied
Interventions
- RADIATION Radiation Therapy
Study Locations (1)
New York
- University of Rochester, Dept. Radiation Oncology - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 1999-11 |
What the finished NCT00178295 record still lists
NCT00178295 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 49-participant average among 9 other Brain Neoplasm trials with a reported enrollment target (10% lower).
The record links to 1 condition, with Brain Neoplasm appearing as the primary indexed condition, and to 1 intervention - of which Radiation Therapy is the first listed.
NCT00178295 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00178295 about?
NCT00178295 is a clinical study titled "Radiation-Induced Cytokine Cascades and Their Correlation With Central Nervous System Injury". Treatment for brain cancer may include radiation therapy. Radiation therapy is the treatment of tumors with X-rays. This study is related to understanding the side effects of radiation treatment for brain tumors. This study is being conducted by the University of Rochester Cancer Center to compare ...
What is the current status of trial NCT00178295?
This trial is currently completed. The enrollment target is 44 participants. The study started on 1999-11.
What conditions does trial NCT00178295 study?
This clinical trial studies the following conditions: Brain Neoplasm.
What interventions are being tested in trial NCT00178295?
The interventions under investigation include: Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT00178295?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00178295 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00178295's enrollment target sits among peer trials
44 5th of 9 higher than 5 of 9 other Brain Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
RECRUITING · Phase 1
-
Tumor Related Epilepsy
RECRUITING
-
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
RECRUITING · Phase 2
-
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
RECRUITING · NA
-
Navigated Repetitive Transcranial Magnetic Stimulation in Improving Motor Rehabilitation in Participants With Brain Tumors
ACTIVE NOT RECRUITING · NA
-
MRI and Blood Biomarkers for the Prediction of Neurocognitive Decline Following Brain Radiation
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia